Celesta Capital

Celesta is delighted to lead the Series A round for OneCell Diagnostics Inc. ?? The capital will support OneCell's expansion into the U.S. market and continued development of its cutting-edge technology for precision oncology liquid biopsy diagnostics. Celesta's Founding Partner Michael E Marks, along with Senior Advisor and Biochemist Nobel Laureate Jim Rothman will join the company's board. Congratulations to CEO Mohan Uttarwar and the whole OneCell team! Read more about the funding in TechCrunch: https://lnkd.in/gkGF96RR

We are proud to announce that we have received an agreement issued by the Centers for Disease Control and Prevention to develop a rapid, point-of-need diagnostic for detecting and differentiating between Influenza A, B, and A/H5 in humans.?With the rise of avian influenza in various species, this collaboration supports advanced preparedness, reducing reliance on central labs while enhancing frontline diagnostic capabilities. Learn more about the agreement and our commitment to global health and pandemic readiness below. https://lnkd.in/gTCrdpJU

Deep tech startups for many years were seen as higher risk, requiring more capital, and offering less potential for strong exits. Today though, many deep tech sectors are attracting more interest than ever before from VCs. However, this pivot is not so simple. In my decades of experience as an executive and investor in this space, I believe deep tech investing can indeed be a more challenging, nuanced area for successful VC investing and company building – but it is not because of the reasons often assumed. In this article, I share the most common misperceptions I observe within deep tech VC, along with some ideas for entrepreneurs and investors to consider.

Out now on the TechSurge Podcast, we're featuring Andy Lee and Anand Chandrasekaran from Crescendo, sharing their vision for the future of AI-powered customer service, with Celesta Managing Partner Sriram Viswanathan. Learn about their innovative approach to integrating AI into business process outsourcing. ?? Link to listen ?? https://lnkd.in/gbjRU4di

We're thrilled to welcome Nobel Laureate Biochemist Dr. James Rothman as a Senior Advisor at Celesta. His expertise will be instrumental in propelling our bio-convergence companies to new heights. Read more here ?? https://lnkd.in/gTcUSx7H

Today, we are excited to finally be able to share our collaboration with and investment from Juniper Networks. At Recogni, we have made it our mission to make GenAI inference profitable, sustainable, and accurate. That’s why we are developing chips and systems based on our proprietary logarithmic math number system, Pareto. And we collaborate in this mission with Juniper, whose expertise as a leader in secure, AI-Native Networking makes them a natural fit. The result? A multimodal GenAI inference system that runs the world's largest GenAI models at uncompromised 16-bit accuracy while operating at a power efficiency equivalent to 4-bit. In other words: Much cheaper GenAI production at scale, unlocking radically new applications, such as real-time AI video generation and AI agents for education and health. And this is just the beginning! Link to the press release in the comments ??

The Future of Construction is Here. Tune in to our latest TechSurge podcast to learn how these leaders in tech are reimagining the industry. An insightful conversation with Trevor Schick, Ash Bhardwaj, and Camilo Restrepo. Link to listen is in the comments. ?? Slate Technologies Inc. Onx Homes Biomason

Faris Sbahi, CEO and Co-Founder of Celesta portfolio company Normal Computing, sat down with us to discuss the pioneering advancements they are developing for AI and its use in complex, high-stakes workflows.? Check out the full conversation in the comments???

Housing construction is a part of the fabric of our families, communities, and nations. It is also one of the largest industries in the world by GDP. And it faces some of the biggest existential challenges of any industry out there - home prices continue to inflate much more rapidly than wages; it has one of the biggest carbon footprints in the world; and its productivity has stagnated for a long time. There are many issues contributing to this, but an overall lack of innovation is chief among them. Emerging startups focused on streamlined business models, more use of data, and development of new technologies are starting to change this reality and I recently had the chance to speak with the CEOs of three companies in this space: ?? Biomason, developer of biologically derived cement materials for sustainable construction ?? Onx Homes, a vertically integrated, industrialized home designer and builder ?? Slate Technologies Inc., an AI virtual assistant platform designed to increase construction productivity Check out our fascinating discussion to hear more about how we are getting closer to more resilient, cost-effective, and environmentally friendly construction: https://lnkd.in/gjE3TewB Trevor Schick Camilo Restrepo Celesta Capital